862270-48-2

Basic information

• Product Name: (R)-1-(1-(4-FLUOROPHENYL)ETHYL)PIPERAZINE
• Synonyms: (R)-1-(1-(4-FLUOROPHENYL)ETHYL)PIPERAZINE
• CAS NO: 862270-48-2
• Molecular Formula: C₁₂H₁₇FN₂
• Molecular Weight: 208.28
• Mol File: 862270-48-2.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: (R)-1-(1-(4-FLUOROPHENYL)ETHYL)PIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-(1-(4-FLUOROPHENYL)ETHYL)PIPERAZINE(862270-48-2)
• EPA Substance Registry System: (R)-1-(1-(4-FLUOROPHENYL)ETHYL)PIPERAZINE(862270-48-2)

Safety Data

• Hazardous Substances Data: 862270-48-2(Hazardous Substances Data)

Usage

General Description

"(R)-1-(1-(4-Fluorophenyl)ethyl)piperazine, also known as 4-F-PEP, is a psychoactive substance and a derivative of piperazine. It is structurally related to other psychoactive substances such as mCPP and TFMPP. 4-F-PEP is a designer drug, meaning it is created in a laboratory and not approved for medical use. The substance is known to have stimulant and hallucinogenic effects, and has been associated with adverse effects such as increased heart rate, elevated blood pressure, agitation, and anxiety. Due to its potential for abuse and harmful effects, it is illegal in many countries and is not recommended for use."

Upstream product

• 862270-47-1 1-[(R)-1-(4-fluorophenyl)ethyl]-4-(toluene-4-sulfonyl)piperazine 
• 821-48-7 bis-(2-chloroethyl)amine hydrochloride 
• 374898-01-8 (R)-1-(4-fluorophenyl)ethylamine 

Downstream Products

• 1020064-27-0 4-chloro-6-{4-[(R)-1-(4-fluoro-phenyl)-ethyl]-piperazin-1-yl}-pyrimidine 
• 1020064-28-1 4,6-bis-{4-[(R)-1-(4-fluoro-phenyl)-ethyl]-piperazin-1-yl}-pyrimidine 

Relevant articles and documents

Practical synthesis of a vanilloid receptor-1 antagonist

(Chemical Equation Presented) Small molecule TRPV1 antagonists have been a recent focus in the search for pain treatment agents. We herein describe a practical and scalable synthesis of AMG 628 (1), a bis-substituted pyrimidine derivative that was identif

VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS

Pyrimidine ethers and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.